Trending:Prolific biotech co-founder and University of Washington scientist , head of the UW Institute for Protein Design, has launched a new company., based in London, harnesses deep learning to uncover new compounds against targets for cancer and other therapeutic areas. The company this week announced $50 million in Series A financing.Baker is a scientific co-founder along with CEO , previously a machine learning engineer at drug discovery company Exscientia and founder of Genei, another computationally-powered biotech company.Charm Therapeutics’ deep learning platform, , was developed...…Trending:Prolific biotech co-founder and University of Washington scientist , head of the UW Institute for Protein Design, has launched a new company., based in London, harnesses deep learning to uncover new compounds against targets for cancer and other therapeutic areas. The company this week announced $50 million in Series A financing.Baker is a scientific co-founder along with CEO , previously a machine learning engineer at drug discovery company Exscientia and founder of Genei, another computationally-powered biotech company.Charm Therapeutics’ deep learning platform, , was developed...WW…